Reopening Safely with Health Check
Covid-19 has dominated most of 2020. It has changed the way we live, work and socialize. It is hard to think of an aspect of life that has gone untouched by the pandemic. For a long time, normal felt like a faraway dream. Now, as vaccines are being prepared to ship across the country as early as next week, something close to normalcy may not be so out of reach.
Pfizer, in collaboration with BioNTech, has requested emergency authorization from the F.D.A. and the panel is expected to give the vaccine, BNT162B2, a greenlight sometime this weekend. Once approved, the first round of the vaccine will be administered to healthcare workers as the first to receive it.
Moderna Therapeutics, with a vaccine in its third phase of clinical trials, is expected to follow suit before the end of the year.